These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS). Baratti D; Kusamura S; Azmi N; Guaglio M; Montenovo M; Deraco M Ann Surg Oncol; 2020 Jan; 27(1):98-106. PubMed ID: 31691116 [TBL] [Abstract][Full Text] [Related]
23. Morbidity and mortality outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients aged 75 years and over: Spanish group of peritoneal cancer surgery (GECOP) multicenter study. Cascales-Campos PA; López-López V; Muñoz-Casares FC; Feliciangeli E; Torres Melero J; Barrios P; Morales R; Ramos I; Ortega G; Camps B; González-Bayón L; Bretcha-Boix P; Farré-Alegre J; González-Moreno S; Gil J Surg Oncol; 2016 Jun; 25(2):111-6. PubMed ID: 27312037 [TBL] [Abstract][Full Text] [Related]
24. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis. Vassos N; Förtsch T; Aladashvili A; Hohenberger W; Croner RS World J Surg Oncol; 2016 Feb; 14(1):42. PubMed ID: 26912149 [TBL] [Abstract][Full Text] [Related]
26. Survival prognostic factors in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy treatment: analysis from a single oncological center. Graziosi L; Marino E; De Angelis V; Rebonato A; Donini A World J Surg Oncol; 2016 Mar; 14():97. PubMed ID: 27036213 [TBL] [Abstract][Full Text] [Related]
27. Cost Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Management of Colorectal Peritoneal Carcinomatosis. Lee ZJ; Chia SL; Tan G; Soo KC; Teo CCM Ann Surg Oncol; 2018 Aug; 25(8):2340-2346. PubMed ID: 29948417 [TBL] [Abstract][Full Text] [Related]
28. Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. Goéré D; Souadka A; Faron M; Cloutier AS; Viana B; Honoré C; Dumont F; Elias D Ann Surg Oncol; 2015 Sep; 22(9):2958-64. PubMed ID: 25631064 [TBL] [Abstract][Full Text] [Related]
29. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastases from Endometrial Cancer. Cornali T; Sammartino P; Kopanakis N; Christopoulou A; Framarino Dei Malatesta M; Efstathiou E; Spagnoli A; Ciardi A; Biacchi D; Spiliotis J Ann Surg Oncol; 2018 Mar; 25(3):679-687. PubMed ID: 29282600 [TBL] [Abstract][Full Text] [Related]
30. Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience. Feferman Y; Solomon D; Bhagwandin S; Kim J; Aycart SN; Feingold D; Sarpel U; Labow DM Ann Surg Oncol; 2019 Feb; 26(2):482-489. PubMed ID: 30539491 [TBL] [Abstract][Full Text] [Related]
31. Indications and outcomes for repeat cytoreductive surgery and heated intra-peritoneal chemotherapy in peritoneal surface malignancy. Sutton PA; O'Dwyer ST; Barriuso J; Aziz O; Selvasekar CR; Renehan AG; Wilson MS Surg Oncol; 2021 Sep; 38():101572. PubMed ID: 33915487 [TBL] [Abstract][Full Text] [Related]
32. Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: the experience of a tertiary Asian center. Teo MC; Ching Tan GH; Lim C; Chia CS; Tham CK; Soo KC Asian J Surg; 2015 Apr; 38(2):65-73. PubMed ID: 25059814 [TBL] [Abstract][Full Text] [Related]
33. Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC. Sluiter NR; Rovers KP; Salhi Y; Vlek SL; Coupé VMH; Verheul HMW; Kazemier G; de Hingh IHJT; Tuynman JB Ann Surg Oncol; 2018 Aug; 25(8):2347-2356. PubMed ID: 29855834 [TBL] [Abstract][Full Text] [Related]
34. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Braam HJ; van Oudheusden TR; de Hingh IH; Nienhuijs SW; Boerma D; Wiezer MJ; van Ramshorst B J Surg Oncol; 2014 Jun; 109(8):841-7. PubMed ID: 24619813 [TBL] [Abstract][Full Text] [Related]
35. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution. Teo MC; Tan GH; Tham CK; Lim C; Soo KC Ann Surg Oncol; 2013 Sep; 20(9):2968-74. PubMed ID: 23504144 [TBL] [Abstract][Full Text] [Related]
36. Linear Relationship of Peritoneal Cancer Index and Survival in Patients with Peritoneal Metastases from Colorectal Cancer. Faron M; Macovei R; Goéré D; Honoré C; Benhaim L; Elias D Ann Surg Oncol; 2016 Jan; 23(1):114-9. PubMed ID: 26014158 [TBL] [Abstract][Full Text] [Related]
37. Does Primary Tumor Side Matter in Patients with Metastatic Colon Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy? Kelly KJ; Alsayadnasser M; Vaida F; Veerapong J; Baumgartner JM; Patel S; Ahmad S; Barone R; Lowy AM Ann Surg Oncol; 2019 May; 26(5):1421-1427. PubMed ID: 30815802 [TBL] [Abstract][Full Text] [Related]
38. The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis. Esquivel J; Lowy AM; Markman M; Chua T; Pelz J; Baratti D; Baumgartner JM; Berri R; Bretcha-Boix P; Deraco M; Flores-Ayala G; Glehen O; Gomez-Portilla A; González-Moreno S; Goodman M; Halkia E; Kusamura S; Moller M; Passot G; Pocard M; Salti G; Sardi A; Senthil M; Spilioitis J; Torres-Melero J; Turaga K; Trout R Ann Surg Oncol; 2014 Dec; 21(13):4195-201. PubMed ID: 24854493 [TBL] [Abstract][Full Text] [Related]
39. Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry. Votanopoulos KI; Sugarbaker P; Deraco M; Morris D; Glehen O; Elias D; De Simone M; Robella M; Heyd B; Kusamura S; Baratti D; Chouliaras K; Russell G; Shen P; Levine EA; Ann Surg Oncol; 2018 Mar; 25(3):667-673. PubMed ID: 29260418 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of repeat cytoreductive surgery and heated intraperitoneal chemotherapy for patients with recurrent peritoneal carcinomatosis from appendiceal and colorectal cancers: a multicentre Canadian study. Jost E; Mack LA; Sideris L; Dube P; Temple W; Bouchard-Fortier A Can J Surg; 2020 Feb; 63(1):E71-E79. PubMed ID: 32080999 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]